ALB - Albemarle Corporation
NYSE
->
Basic Materials
->
Specialty Chemicals
Charlotte,
United States
Type: Equity
ALB price evolution
ALB
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1830.23 | $2055.81 | $889.9 | |
| Short term investments | ||||
| Net receivables | $1218.93 | $1197.73 | $1312.55 | $1722.26 |
| Inventory | $1657.69 | $1800.11 | $1904.83 | $2161.29 |
| Total current assets | $4669.61 | $5225.7 | $5822.73 | $5216.92 |
| Long term investments | $1160.67 | $1259 | $1369.86 | |
| Property, plant & equipment | $9381.2 | $9837.03 | $9756.03 | $9495.2 |
| Goodwill & intangible assets | $1844.27 | $1865.29 | $1891.59 | |
| Total noncurrent assets | $13162.58 | $13209.61 | $13053.73 | |
| Total investments | $1160.67 | $1259 | $1369.86 | |
| Total assets | $17455.19 | $18388.28 | $19032.33 | $18270.65 |
| Current liabilities | ||||
| Accounts payable | $1222.81 | $1323.17 | $1295.57 | $2088.05 |
| Deferred revenue | ||||
| Short long term debt | $3.21 | $5.08 | $625.76 | |
| Total current liabilities | $1910.72 | $1958.46 | $2050.7 | $3560.46 |
| Long term debt | $3565.99 | $3519.5 | $3519.45 | $3541 |
| Total noncurrent liabilities | $4946.67 | $5181.92 | $5045.09 | |
| Total debt | $3522.72 | $3524.53 | $4166.76 | |
| Total liabilities | $7214.59 | $6905.13 | $7232.61 | $8605.55 |
| Shareholders' equity | ||||
| Retained earnings | $5495.7 | $6653.98 | $6930.87 | $6987.02 |
| Other shareholder equity | -$469.77 | -$637.55 | -$597.21 | -$528.53 |
| Total shareholder equity | $11222.56 | $11532.8 | $9412.18 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $889.9 | $1499.14 | $439.27 | $746.72 |
| Short term investments | ||||
| Net receivables | $1722.26 | $1448.58 | $623.11 | $592.8 |
| Inventory | $2161.29 | $2076.03 | $812.92 | $750.24 |
| Total current assets | $5216.92 | $5186.92 | $2007.98 | $2206.18 |
| Long term investments | $1369.86 | $1150.55 | $897.71 | $656.24 |
| Property, plant & equipment | $9495.2 | $7091.17 | $5909.62 | $5354.63 |
| Goodwill & intangible assets | $1891.59 | $1905.5 | $1906.57 | $2014.63 |
| Total noncurrent assets | $13053.73 | $10269.6 | $8966.14 | $8244.76 |
| Total investments | $1369.86 | $1150.55 | $897.71 | $656.24 |
| Total assets | $18270.65 | $15456.52 | $10974.12 | $10450.95 |
| Current liabilities | ||||
| Accounts payable | $2088.05 | $2052 | $647.99 | $483.22 |
| Deferred revenue | ||||
| Short long term debt | $625.76 | $2.13 | $389.92 | $804.68 |
| Total current liabilities | $3560.46 | $2741.01 | $1874.34 | $1801.85 |
| Long term debt | $3541 | $3214.97 | $2004.32 | $2767.38 |
| Total noncurrent liabilities | $5045.09 | $4524.66 | $3294.18 | $4180.5 |
| Total debt | $4166.76 | $3217.1 | $2394.24 | $3572.06 |
| Total liabilities | $8605.55 | $7473.9 | $5168.51 | $5982.35 |
| Shareholders' equity | ||||
| Retained earnings | $6987.02 | $5601.28 | $3096.54 | $3155.25 |
| Other shareholder equity | -$528.53 | -$560.66 | -$392.45 | -$326.13 |
| Total shareholder equity | $9412.18 | $7982.63 | $5625.27 | $4268.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1354.69 | $1430.38 | $1360.74 | $2356.16 |
| Cost of revenue | $1440.96 | $1321.8 | $3060.22 | |
| Gross Profit | -$104.03 | -$10.58 | $38.94 | -$704.05 |
| Operating activities | ||||
| Research & development | $20.77 | $23.53 | $22.75 | |
| Selling, general & administrative | $168.95 | $194.91 | $194.25 | |
| Total operating expenses | $176.11 | $482.03 | $218.44 | $145.81 |
| Operating income | -$492.61 | -$179.51 | -$849.87 | |
| Income from continuing operations | ||||
| EBIT | -$183.67 | $36.7 | -$464.42 | |
| Income tax expense | $110.85 | -$30.66 | -$3.72 | $118.88 |
| Interest expense | -$47.77 | $35.19 | $37.97 | $34.39 |
| Net income | ||||
| Net income | -$1110.68 | -$188.2 | $2.45 | -$617.68 |
| Income (for common shares) | -$229.89 | -$9.14 | -$617.68 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9617.2 | $7320.1 | $3327.96 | $3128.91 |
| Cost of revenue | $8431.29 | $4245.52 | $2329.99 | $2134.06 |
| Gross Profit | $1185.91 | $3074.59 | $997.97 | $994.85 |
| Operating activities | ||||
| Research & development | $85.72 | $71.98 | $54.03 | $59.21 |
| Selling, general & administrative | $919.49 | $524.14 | $441.48 | $429.83 |
| Total operating expenses | $934.03 | $604.53 | $199.54 | $489.04 |
| Operating income | $251.88 | $2470.06 | $798.43 | $505.81 |
| Income from continuing operations | ||||
| EBIT | $2119.82 | $3203.38 | $214.59 | $503.31 |
| Income tax expense | $430.28 | $390.59 | $29.45 | $54.42 |
| Interest expense | $116.07 | $122.97 | $61.48 | $73.12 |
| Net income | ||||
| Net income | $1573.48 | $2689.82 | $123.67 | $375.76 |
| Income (for common shares) | $1573.48 | $2689.82 | $123.67 | $375.76 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$188.2 | $2.45 | -$617.68 | |
| Operating activities | ||||
| Depreciation | $138.28 | $123.75 | $144.14 | |
| Business acquisitions & disposals | -$383.02 | |||
| Stock-based compensation | $6.12 | $9.32 | $7.08 | |
| Total cash flows from operations | $362.89 | $97.95 | -$98.22 | |
| Investing activities | ||||
| Capital expenditures | -$447.61 | -$579.32 | -$684.09 | |
| Investments | -$2.39 | $84.82 | $1.58 | |
| Total cash flows from investing | -$1246.63 | -$450 | -$494.5 | -$1065.53 |
| Financing activities | ||||
| Dividends paid | -$221.99 | -$47.01 | -$46.91 | -$46.94 |
| Sale and purchase of stock | $0.09 | $0.07 | ||
| Net borrowings | -$6.64 | -$620.75 | $471.41 | |
| Total cash flows from financing | $1334.62 | -$112.72 | $1557.3 | $397 |
| Effect of exchange rate | -$14.76 | -$25.76 | $5.16 | $54.98 |
| Change in cash and equivalents | $774.62 | -$225.59 | $1165.91 | -$711.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1573.48 | $2689.82 | $123.67 | $375.76 |
| Operating activities | ||||
| Depreciation | $429.94 | $300.84 | $254 | $231.98 |
| Business acquisitions & disposals | -$426.23 | -$162.24 | $289.79 | -$11.57 |
| Stock-based compensation | $36.55 | $30.47 | $20.12 | $22.84 |
| Total cash flows from operations | $1325.32 | $1907.85 | $344.26 | $798.91 |
| Investing activities | ||||
| Capital expenditures | -$2149.28 | -$1261.65 | -$953.67 | -$850.48 |
| Investments | -$205.65 | $1.24 | -$2.71 | -$1.52 |
| Total cash flows from investing | -$2781.16 | -$1422.65 | -$666.59 | -$863.57 |
| Financing activities | ||||
| Dividends paid | -$187.19 | -$184.43 | -$177.85 | -$161.82 |
| Sale and purchase of stock | $0.19 | $2.78 | $1472.28 | $40.44 |
| Net borrowings | $944.2 | $867.55 | -$1112.83 | $339.8 |
| Total cash flows from financing | $623.91 | $611.89 | $50.21 | $177.26 |
| Effect of exchange rate | $222.69 | -$37.22 | -$35.33 | $21.01 |
| Change in cash and equivalents | -$609.24 | $1059.87 | -$307.45 | $133.61 |
News
|
Albemarle Co. (NYSE:ALB) Shares Sold by Allworth Financial LP
ETF DAILY NEWS
22 Feb 2025
|
|
Rhumbline Advisers Sells 6,756 Shares of Albemarle Co. (NYSE:ALB)
ETF DAILY NEWS
22 Feb 2025
|
|
Scotiabank Forecasts Albemarle’s Q1 Earnings (NYSE:ALB)
ETF DAILY NEWS
21 Feb 2025
|
|
Albemarle (NYSE:ALB) Price Target Cut to $68.00 by Analysts at Morgan Stanley
ETF DAILY NEWS
20 Feb 2025
|
|
3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2%
Simply Wall St. · via Yahoo Finance
19 Feb 2025
|
|
Albemarle (NYSE:ALB) Price Target Lowered to $85.00 at Truist Financial
ETF DAILY NEWS
16 Feb 2025
|
|
UBS Group Issues Pessimistic Forecast for Albemarle (NYSE:ALB) Stock Price
ETF DAILY NEWS
15 Feb 2025
|
|
Mizuho cuts Albemarle stock price target to $90 from $105 By Investing.com
Investing.com
13 Feb 2025
|
|
Albemarle (ALB) Q4 2024 Earnings Call Transcript
Motley Fool · via Yahoo Finance
13 Feb 2025
|
|
Albemarle's Q4 Earnings and Sales Miss Estimates on Lower Pricing
Zacks · via Yahoo Finance
13 Feb 2025
|
Fundamentals
| Market cap | $17.15B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 117.54M |
| Revenue | $6.50B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$1.91B |
| Revenue Q/Q | -41.37% |
| Revenue Y/Y | -34.20% |
| P/E ratio | -8.96 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.64 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$16.29 |
|---|---|
| ROA | -10.47% |
| ROE | N/A |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.44 |
| Quick ratio | 1.58 |